Retension Pharmaceutical

Developer of therapeutic drugs designed for patients with hypertension. The company's drug is a unique second-generation inhibitor that preferentially targets cardiovascular tissues, enabling patients...

Healthcare

Falls Church, VA, United States

Founded 2023

9 employees

Website

Valuation

$50M

Market implied

Share Price

N/A

Total Raised

$22.4M

Last Round

N/A

Investors

+3 other investors

View all 3 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Retension Pharmaceutical's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required